Leading Pharmaceutical Company reduces cybersecurity incidents by 48% and improves compliance with Loglix SOC-as-a-Service

‍Business overview & challenge

A leading Pharmaceutical company faced an escalating number of cybersecurity threats targeting their proprietary research data, patient records, and intellectual property. The company needed to augment its cybersecurity posture, safeguard its vital assets, and ensure compliance with industry regulations such as HIPAA and FDA 21 CFR Part 11. A significant challenge was managing these risks while maintaining focus on their core competency developing life-saving drugs and treatments.

Solution

The Pharmaceutical company enlisted Loglix SOC-as-a-Service to provide around-the-clock security monitoring, incident response, and strategic leadership for their cyber security initiatives. Key components of Loglix service included:

• ‍24/7 Security Monitoring: Our team conducted continuous monitoring of the company's network and systems, promptly identifying and addressing security threats.
• Incident Response: In case of any security incidents, our team acted swiftly to mitigate the impact and prevent further damage.
• Vulnerability Management: We continuously identified, classified, prioritized, and remediated vulnerabilities in the company's system, thereby preventing potential breaches.
• Compliance Management: Our service ensured adherence to pharmaceutical industry regulations such as HIPAA and FDA 21 CFR Part 11, providing detailed compliance reports.
• Security Awareness Training: We provided training to the company's staff, fostering a culture of cybersecurity awareness.

Results

As a result of Loglix SOC-as-a-Service, the Pharmaceutical company achieved a 48% reduction in cybersecurity incidents, substantially enhancing the protection of sensitive research data, patient records, and intellectual property. The stream lined compliance processes ensured adherence to HIPAA and FDA 21 CFR Part 11, helping avoid potential non-compliance penalties.

With Loglix SOC-as-a-Service, the Pharmaceutical company achieved a 48% reduction in cybersecurity incidents, substantially enhancing the protection of sensitive patient records and intellectual property

With an improved overall cybersecurity posture and a dedicated team managing security operations around the clock, the company could focus on its core business, secure in the knowledge that its vital data and systems were protected. This also led to increased trust from partners, stakeholders, and customers, who recognized the company's commitment to cybersecurity.